Emerging Infectious Disease ISSN: 1080-6059

Pediatric Parapneumonic Empyema, Spain

Ignacio Obando

, Carmen Muñoz-Almagro, Luis A. Arroyo, David Tarrago, David Sanchez-Tatay, David Moreno-Perez, Sahar S. Dhillon, Cristina Esteva, Susanna Hernandez-Bou, Juan J. Garcia-Garcia, William P. Hausdorff, and Angela B. Brueggemann

Author affiliations: Virgen del Rocio Children’s Hospital, Seville, Spain (I. Obando, L.A. Arroyo, D. Sanchez-Tatay); Sant Joan de Deu Hospital, Barcelona, Spain (C. Muñoz-Almagro, C. Esteva, S. Hernandez-Bou, J.J. Garcia-Garcia); Spanish Reference Laboratory for Pneumococci, Madrid, Spain (D. Tarrago); Carlos de Haya Children’s Hospital, Malaga, Spain (D. Moreno-Perez); University of Oxford, Oxford, UK (S.S. Dhillon, A.B. Brueggemann);; GlaxoSmithKline Biologicals, Rixensart, Belgium (W.P. Hausdorff);

Main Article

Figure 1

Annual number of pediatric parapneumonic empyema (PPE) cases among children <14 years of age admitted to Seville and Malaga hospitals from 1998 to June 2006 (combined prospective and retrospective data) and among children <18 years of age admitted to a Barcelona hospital from October 2003 through June 2006. *October 1, 2003, through December 31, 2003.

Figure 1. Annual number of pediatric parapneumonic empyema (PPE) cases among children <14 years of age admitted to Seville and Malaga hospitals from 1998 to June 2006 (combined prospective and retrospective data) and among children <18 years of age admitted to a Barcelona hospital from October 2003 through June 2006. *October 1, 2003, through December 31, 2003.

Main Article

Top of Page

The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.